Zhang HH - Search Results

1

[Inhibition of CD4+ CD25+ regulatory T cells in chronic hepatitis B patients].

Zhang HH, Guo F, Fei R, Ma H, Cong X, Wei L, Chen HS. Zhang HH, et al. Zhonghua Yi Xue Za Zhi. 2008 Feb 26;88(8):511-5. Zhonghua Yi Xue Za Zhi. 2008. PMID: 18649763 Chinese.

2

[Construction of HLA-A2-peptide tetramer and application in HBV/HCV infection].

Piao WH, He Y, Xi HL, Sun XT, Zhang HH, Xu JH, Zhao H, Xu WX, Li ZL, Wang GQ. Piao WH, et al. Among authors: zhang hh. Zhonghua Yi Xue Za Zhi. 2004 Nov 2;84(21):1818-22. Zhonghua Yi Xue Za Zhi. 2004. PMID: 15631781 Chinese.

3

[Study of phenotypes and functions of cord blood dendritic cells from fetuses whose mothers had chronic hepatitis B].

Zhang HH, Yang HX, Xi HL, He Y, Piao WH, Zhao H, Yu M, Wang GQ. Zhang HH, et al. Zhonghua Gan Zang Bing Za Zhi. 2005 Jun;13(6):417-20. Zhonghua Gan Zang Bing Za Zhi. 2005. PMID: 15975273 Chinese.

4

[The effect of stimulation of dendritic cell on HBV-epitopic cytotoxic T-lymphocyte].

Zhang HH, He Y, Zhao H, Piao WH, Liu MC, Xi HL, Yu M, Wang GQ. Zhang HH, et al. Zhonghua Yi Xue Za Zhi. 2005 May 11;85(17):1171-6. Zhonghua Yi Xue Za Zhi. 2005. PMID: 16029590 Chinese.

5

[The frequency, phenotypes and functions of CD4+ CD25+ regulatory T cells in hepatocellular carcinoma patients].

Zhang HH, Fei R, Mei MH, Liao WJ, Wang XY, Cong X, Qin LL, Ji Y, Wang SX, Wei L, Chen HS. Zhang HH, et al. Zhonghua Gan Zang Bing Za Zhi. 2007 Apr;15(4):266-72. Zhonghua Gan Zang Bing Za Zhi. 2007. PMID: 17456313 Chinese.

6

The functional evaluation of dendritic cell vaccines based on different hepatitis C virus nonstructural genes.

Tian Y, Zhang HH, Wei L, Du SC, Chen HS, Fei R, Liu F. Tian Y, et al. Among authors: zhang hh. Viral Immunol. 2007 Dec;20(4):553-61. doi: 10.1089/vim.2007.0064. Viral Immunol. 2007. PMID: 18158729

7

Comparisons for detecting NY-ESO-1 mRNA expression levels in hepatocellular carcinoma tissues.

Wang XY, Chen HS, Luo S, Zhang HH, Fei R, Cai J. Wang XY, et al. Among authors: zhang hh. Oncol Rep. 2009 Mar;21(3):713-9. Oncol Rep. 2009. PMID: 19212631

8

Expression of CIITA-related MHCII molecules in tumors linked to prognosis in hepatocellular carcinoma.

Xie XW, Mei MH, Liao WJ, Qian LH, Yu X, Fei R, Qin LL, Zhang HH, Peng JR, Shen DH, Wei L, Chen HS. Xie XW, et al. Among authors: zhang hh. Int J Oncol. 2009 Mar;34(3):681-8. doi: 10.3892/ijo_00000194. Int J Oncol. 2009. PMID: 19212673

9

Proteome responses to stable hepatitis B virus transfection and following interferon alpha treatment in human liver cell line HepG2.

Wang J, Jiang D, Zhang H, Lv S, Rao H, Fei R, Wei L. Wang J, et al. Proteomics. 2009 Mar;9(6):1672-82. doi: 10.1002/pmic.200800621. Proteomics. 2009. PMID: 19242931

10

[Specific suppression in regulatory T cells by Foxp3 siRNA contributes to enhance the in vitro anti-tumor immune response in hepatocellular carcinoma patients].

Zhang HH, Fei R, Xie XW, Wang L, Luo H, Wang XY, Wei L, Chen HS. Zhang HH, et al. Beijing Da Xue Xue Bao Yi Xue Ban. 2009 Jun 18;41(3):313-8. Beijing Da Xue Xue Bao Yi Xue Ban. 2009. PMID: 19727215 Free article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,195 results

Search Page

Filters